Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialPhilippe Armand, Leo I. Gordon, Edmund K. Waller et al.|Journal of Clinical Oncology|2013Cited by 439
Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes RegistryRachel Cusatis, Bronwen E. Shaw, Lori Muffly et al.|Transplantation and Cellular Therapy|2021Cited by 13